IPCA Laboratories Limited — Financials & Forensics
Sector: Healthcare · NSE: IPCALAB · BSE: 524494 · ISIN: INE571A01038
18 Aug 2026
Add IPCALAB to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹5,830 Cr | ₹6,244 Cr | ₹7,705 Cr | ₹8,940 Cr | ₹9,646 Cr |
| EBITDA | ₹1,309 Cr | ₹927 Cr | ₹1,321 Cr | ₹1,726 Cr | ₹1,979 Cr |
| EBITDA margin | 22.5% | 14.8% | 17.1% | 19.3% | 20.5% |
| Profit after tax | ₹884 Cr | ₹471 Cr | ₹547 Cr | ₹738 Cr | ₹1,141 Cr |
Deeper analysis
Recent filings by IPCA Laboratories Limited
-
Proceedings of AGM
13 Aug 2026 · General Update
-
Standalone and Consolidated Unaudited Financial Results for Q1FY27
13 Aug 2026 · Board Meeting
Never miss a filing again
About IPCA Laboratories Limited on Indian Stock Alerts
Indian Stock Alerts tracks IPCA Laboratories Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.